Effectiveness of Antimicrobial Stewardship in Cancer Patients
Author Information
Author(s): Naoya Itoh, Nana Akazawa-Kai, Makoto Yamaguchi, Takanori Kawabata
Primary Institution: Aichi Cancer Center Hospital
Hypothesis
Can a long-term antimicrobial stewardship program improve antibiotic use and patient outcomes in cancer patients?
Conclusion
The 46-month antimicrobial stewardship program led to reduced carbapenem use and shorter hospital stays without negatively impacting patient mortality.
Supporting Evidence
- The days of therapy for carbapenems significantly decreased after the intervention.
- The length of hospital stay was significantly reduced.
- The rate of appropriate use of antimicrobial agents increased significantly during the late postintervention period.
- All-cause in-hospital mortality rates were numerically reduced, though not significantly.
Takeaway
A program to manage antibiotics for cancer patients helped use the right medicines better and made hospital stays shorter.
Methodology
A single-center, retrospective, observational study comparing preintervention and postintervention phases over 46 months.
Potential Biases
Potential bias due to the observational nature of the study and the influence of external factors like COVID-19.
Limitations
The study was conducted at a single center, limiting generalizability, and was affected by antimicrobial shortages.
Participant Demographics
Patients admitted to Aichi Cancer Center, with a focus on those receiving antimicrobial treatment.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI, −2.04 to −.97
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website